Rayence Co., Ltd. (KOSDAQ:228850)

Market Cap	93.63B
Revenue (ttm)	113.14B
Net Income (ttm)	-369.01M
Shares Out	15.74M
EPS (ttm)	-23.44
PE Ratio	n/a
Forward PE	17.17
Dividend	100.00 (1.68%)
Ex-Dividend Date	Dec 27, 2024

Volume	37,869
Average Volume	13,215
Open	5,920.00
Previous Close	5,860.00
Day's Range	5,820.00 - 5,970.00
52-Week Range	5,620.00 - 8,500.00
Beta	0.58
RSI	43.25
Earnings Date	Nov 11, 2025

About Rayence

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides rad...

• Industry: X-Ray Apparatus and Tubes and Related Irradiation Apparatus
• Founded: 2011
• Employees: 228
• Stock Exchange: KOSDAQ
• Ticker Symbol: 228850

Financial Performance

In 2024, Rayence's revenue was 125.56 billion, a decrease of -12.18% compared to the previous year's 142.99 billion. Earnings were 7.83 billion, a decrease of -60.05%.